Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 539 results found. Search for [ Oxford University ]

Results 1 to 21 of 539
BusinessToday.In
December 3, 2020
Serum Institute's chief executive officer, Adar Poonawalla, has confirmed that the company's coronavirus vaccine will enter the open market post-March to April 2021 if the vaccine is found to be 'immunogenic and safe'


Associated Press
December 2, 2020
The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe's deadliest COVID-19 outbreak


BusinessToday.In
December 1, 2020
In a statement, SII said the incident with the Chennai volunteer, though highly unfortunate, was in no way induced by the vaccine and that SII is sympathetic with the volunteer's medical condition


BusinessToday.In
November 30, 2020
As number of patients has doubled from 95 to 196, Moderna has reported a drop in efficacy for its COVID-19 vaccine from 94.5 per cent to 94.1 per cent


BusinessToday.In
November 30, 2020
PM Modi asks teams to come out with ideas on regulatory processes and related matters. As pharma companies move ahead with their clinical trials, the government has also stepped up efforts to devise the vaccine distribution plan


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
November 29, 2020
A 40-year-old Chennai-based man had alleged that he suffered serious side effects following vaccination and sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial


PTI
November 29, 2020
The legal notice has been sent to Pune based Serum Institute of India, which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, 'Covidshield.'


BusinessToday.In
November 29, 2020
India to develop vaccines for 60 percent of developing nations; 24 manufacturing units among 19 firms to develop vaccine in India: Bhargava


PTI
November 29, 2020
After making rounds everywhere in the world, the vaccine on COVID-19 would be found in Pune. Nothing is beyond Pune, the Baramati MP said


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


BusinessToday.In
November 28, 2020
The British-Swedish drug maker AstraZeneca would also submit the current data set to the Indian regulator within the stipulated time, and also provide additional study results


PTI
November 28, 2020
PM Modi landed at Hakimpet Air Force station near here at around 1 pm,as part of his three-city tour to take the stock of COVID-19 vaccine development


Reuters
November 28, 2020
If a vaccine has an efficacy of, say, 80%, it means that if 100 people who have not previously been infected by the coronavirus are given the vaccine, on average 80 of them will not get the disease that the virus causes: COVID-19


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


PAGES 1 OF 27  12345